XML 39 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:    
Net income $ 87,793 $ 91,471
Adjustments to reconcile net income to net cash (used for)/provided by operating activities:    
Tax benefit from the exercise of stock options (10,428) (1,631)
Depreciation and amortization 13,940 10,961
Loss on disposal of fixed assets 989 278
Impairment charge 3,045 0
Deferred taxes (8,890) (1,120)
Forgiveness of note receivable - related party (52) 0
Stock-based compensation 13,609 14,593
Deferred rent 348 1,035
Realized gain (loss) on sale of marketable securities 82 678
Contingent Liability (2,504) (1,378)
Changes, net of acquisitions, in:    
Accounts receivable, net of allowances (12,718) (1,060)
Factor accounts receivable, net of allowances (77,523) (62,079)
Inventories (31,592) (17,075)
Prepaids and other assets 17,448 6,965
Accounts payable and other accrued expenses 56,601 32,416
Net cash (used for)/provided by operating activities 50,148 74,054
Cash flows from investing activities:    
Purchases of property and equipment (13,524) (12,605)
Purchases of marketable securities (28,705) (17,420)
Sales of marketable securities 33,332 112,293
Proceeds from Collection of Notes Receivable 342 383
Acquisitions, net of cash acquired (9,129) (61,414)
Net cash used for investing activities (17,684) 21,237
Cash flows from financing activities:    
Common stock repurchases for treasury (103,892) (101,751)
Proceeds from exercise of stock options 21,154 2,940
Tax benefit from the exercise of stock options 10,428 1,631
Advances from factor (2,950) (8,475)
Net cash used for financing activities (75,260) (105,655)
Net decrease in cash and cash equivalents (42,796) (10,364)
Cash and cash equivalents – beginning of period 81,450 180,275
Cash and cash equivalents – end of period $ 38,654 $ 169,911